COVID vaccines offer the pharma industry a once-in-a-generation opportunity to reset its reputation. But it’s after decades of big profits and scandals
- Written by Ray Moynihan, Assistant Professor, Bond University
Elsa Olofsson/UnsplashJust weeks before the first COVID-19 cases emerged, Gallup published its latest poll on America’s views about business. At the bottom of the list of 25 sectors was the pharmaceutical industry. Below advertising. Below oil and gas. Below the banks.
The pandemic and the new vaccines have of course turned that reputation...
